Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aljoeson Walker

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Insight (American Society of Ophthalmic Registered Nurses)|October 10, 2002
Making a difference through education in the life of the patient with pseudotumor cerebriCarolyn C Cavanaugh, Aljoeson Walker
Current Treatment Options in Neurology|October 3, 2001
NeurosarcoidosisAljoeson Walker, William Tyor
Ethnicity & Disease|July 7, 2012
Response to disease modifying therapies in African Americans with multiple sclerosisSylvia Klineova, Joyce Nicholas, Aljoeson Walker
Expert Review of Neurotherapeutics|October 9, 2009
Therapeutic options in neurosarcoidosisZoltan Kaliszky, Aljoeson Walker, William R Tyor
Archives of Neurology|December 12, 2007
Immunosuppressive or surgical treatment for ocular Myasthenia GravisPamela S Chavis, David E Stickler, Aljoeson Walker
American Journal of Alzheimer'S Disease and Other Dementias|July 21, 2012
APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairmentXiaoyan Sun, Joyce Nicholas, Aljoeson Walker, et al.
The Clinical Neuropsychologist|October 27, 2017
Posterior cortical atrophy of a suspected non-Alzheimer type: a case reportMark T Wagner, Dana M Szeles, Blakely Mulder, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|February 14, 2007
Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohortMark T Wagner, Joy H Wymer, Noelle E Carlozzi, et al.
Metabolic Brain Disease|December 20, 2019
Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibitionRachel Polcyn, Mollie Capone, Denise Matzelle, et al.
Dementia and Geriatric Cognitive Disorders|March 12, 2009
Establishment of a predominantly African-American cohort for the study of Alzheimer's disease: the South Carolina Alzheimer's disease clinical coreDavid L Bachman, Marilyn Stuckey, Myla Ebeling, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Insight (American Society of Ophthalmic Registered Nurses)|October 10, 2002
Making a difference through education in the life of the patient with pseudotumor cerebriCarolyn C Cavanaugh, Aljoeson Walker
Current Treatment Options in Neurology|October 3, 2001
NeurosarcoidosisAljoeson Walker, William Tyor
Ethnicity & Disease|July 7, 2012
Response to disease modifying therapies in African Americans with multiple sclerosisSylvia Klineova, Joyce Nicholas, Aljoeson Walker
Expert Review of Neurotherapeutics|October 9, 2009
Therapeutic options in neurosarcoidosisZoltan Kaliszky, Aljoeson Walker, William R Tyor
Archives of Neurology|December 12, 2007
Immunosuppressive or surgical treatment for ocular Myasthenia GravisPamela S Chavis, David E Stickler, Aljoeson Walker
American Journal of Alzheimer'S Disease and Other Dementias|July 21, 2012
APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairmentXiaoyan Sun, Joyce Nicholas, Aljoeson Walker, et al.
The Clinical Neuropsychologist|October 27, 2017
Posterior cortical atrophy of a suspected non-Alzheimer type: a case reportMark T Wagner, Dana M Szeles, Blakely Mulder, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|February 14, 2007
Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohortMark T Wagner, Joy H Wymer, Noelle E Carlozzi, et al.
Metabolic Brain Disease|December 20, 2019
Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibitionRachel Polcyn, Mollie Capone, Denise Matzelle, et al.
Dementia and Geriatric Cognitive Disorders|March 12, 2009
Establishment of a predominantly African-American cohort for the study of Alzheimer's disease: the South Carolina Alzheimer's disease clinical coreDavid L Bachman, Marilyn Stuckey, Myla Ebeling, et al.
Pageof 2